New method detects telomere length for research into cancer, aging
DALLAS – June 29, 2016 – UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
In broad terms, telomeres help determine whether a cell reproduces accurately. As the cell divides, these endcaps degrade, causing the cell to age – and it is believed this degradation may lead to some aspects of aging in humans. UT Southwestern scientists hope to use knowledge of telomeres to slow or stop cells from aging, or to potentially help stop the uncontrolled growth of cancer cells that maintain their telomeres.
Finding the best and most sensitive methods for measuring telomeres is an important initial step that could eventually enable scientists to encourage healthy cell growth or, in the case of cancer, limit or halt the cell growth.
"Probes generated using this new approach significantly enhance the sensitivity of telomere length measurements," explained Dr. Jerry Shay, Professor of Cell Biology, who along with his postdoctoral fellow, Dr. Tsung-Po Lai, developed the new method together with Dr. Woodring Wright, Professor of Cell Biology and Internal Medicine. Dr. Shay and Dr. Wright, who hold The Southland Financial Corporation Distinguished Chair in Geriatrics, are members of UT Southwestern's Harold C. Simmons Comprehensive Cancer Center, and together direct a joint laboratory studying telomere biology.
Telomeres are the ends of chromosomes, which package genetic information to pass from parents to children. As the cell divides, these endcaps help keep the genetic information stable and prevent the chromosomes from fusing together. But as cells divide, the telomeres shorten and, eventually, trigger DNA damage that in conjunction with other factors can lead to progression of aging and an increased chance of cancer emerging.
Scientists are interesting in understanding this cellular aging process to create an "immortal cell," which could continue to create new cells without degrading and that could have important implications for diseases related to aging. In reverse, controlling the cellular aging process could accelerate the mortality of cancer cells. If telomeres in cancer cells shorten, this action could prevent the cancer cells from dividing uncontrollably in their early stages of development, slowing or halting cancer progression. In the event that a tumor has already developed, anti-telomerase therapy might be administered to prevent relapse.
The first step is developing the ability to accurately measure telomeres. Radioactive probes often used for measuring lengths are less stable, require long exposure times, and result in hazardous waste disposal requirements and other potential safety issues. A popular nonradioactive alternative called DIG (digoxigenin) probes requires relatively large amounts of genomic DNA and is less sensitive. The new nonradioactive method developed by the researchers here uses multiple DIG molecules, which increases both the sensitivity and stability of telomere detection.
The research appears in the journal BioTechniques. The research was conducted with support from Henrietta Lacks and her family; grants from the National Institute on Aging, Cancer Prevention and Research Institute of Texas (CPRIT), and the Harold C. Simmons Comprehensive Cancer Center; and additional support from the Southland Financial Corporation Distinguished Chair in Geriatrics.
UT Southwestern's Simmons Cancer Center is the only NCI-designated Comprehensive Cancer Center in North Texas and one of just 45 NCI-designated Comprehensive Cancer Centers in the nation. The Simmons Cancer Center includes 13 major cancer care programs and fosters groundbreaking basic research that has the potential to improve patient care and prevention of cancer worldwide. The Center's education and training programs support and develop the next generation of cancer researchers and clinicians. The Center also is among only 30 U.S. cancer research centers, and the only cancer center in North Texas to be named a National Clinical Trials Network Lead Academic Participating Site, providing patients access to NCI-sponsored cancer research trials, where promising new drugs often are tested.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of almost 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in about 80 specialties to more than 100,000 hospitalized patients and oversee approximately 2.2 million outpatient visits a year.
This news release is available on our home page at http://www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email, subscribe at http://www.utsouthwestern.edu/receivenews
Lori Sundeen Soderbergh